Sirui et al. [25] found that STING-induced regulatory B cells (Bregs) can compromise NK function in cancer immunity, which provides us a clue that the CD19 + cells in our study may reflect the abundance of regulatory B cells (Bregs) of patients. The gene discussed is CD19; the disease is cancer.